CBE-201

N/A

Report date: 2024/02/28 13:13:31

Base Information

Drug NameCBE-201

Drug Alias NameCBE-201

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionCell replacements

TargetsUpdating

Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCell BioEngines Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsHead and Neck NeoplasmsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A